This review highlights that primary cardiac angiosarcoma is a rare, aggressive tumor best managed with surgical resection for palliation, as it remains largely resistant to chemoradiation.
No takes yet. Share an insight, caveat, or question.
Reinforces surgery-first palliation in practice for this rare tumor; leaves open effective systemic options for future trials.
Marios Loukas (2014) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: